Key result
Antitumor drugs including anthracyclines, immune checkpoint inhibitors, and trastuzumab are associated with significant cardiotoxicity, requiring continuous monitoring with biomarkers and imaging.
Why the study?
Antitumor drugs can cause significant cardiotoxicity that impairs prognosis and survival, necessitating an update on complications, monitoring strategies, and early detection methods.
Design
Review
Authors
Loading...
Reinforces surveillance needs in cardio-oncology patients; leaves optimal protocols and frequency open for prospective trials.
Continuous multimodal monitoring, including advanced imaging techniques like CMR and strain echocardiography, is crucial for the early detection and management of antitumor drug-induced cardiotoxicity.
Huang et al. (2022) conducted a review in Cardiotoxicity after antitumor strategy. Antitumor drugs (Anthracyclines, Immune Checkpoint Inhibitors, Trastuzumab) was evaluated. Antitumor drugs including anthracyclines, immune checkpoint inhibitors, and trastuzumab are associated with significant cardiotoxicity, requiring continuous monitoring with biomarkers and imaging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: